Clinical Topics

Weight, Not Diet, Associated With Higher Veteran Mortality From CRC

by U.S. Medicine

June 15, 2018

MINNEAPOLIS — While suspected, the relationship between dietary and lifestyle risk factors and long-term mortality from colorectal cancer remains poorly understood, according to a new study.

The report in the journal Digestive Diseases and Sciences pointed out that factors such as obesity, intakes of red meat and use of aspirin have all been linked to risk of colorectal cancer mortality, but not all studies have been able to replicate those findings.1

The study led by researchers from the Minneapolis VA Healthcare System and the University of Minnesota sought to add to the understanding of those associations. To do that, they focused on 46,551 participants In the Minnesota Colon Cancer Control Study. The subjects, 50-80 years old were randomly assigned to usual care (control) or annual or biennial screening by fecal occult blood testing.

Dietary intake and lifestyle risk factors were assessed by questionnaires at baseline, with colon cancer mortality assessed after 30 years of follow-up.

Increasing the risk of CRC mortality were age [hazard ratio (HR) 1.09; 95% CI 1.07, -1.11], male sex (HR 1.25; 95% CI 1.01, 1.57), and higher body mass index (BMI) (HR 1.03; 95% CI 1.00-1.05).

Undergoing screening for CRC was associated, however, with a reduced risk of colorectal cancer mortality (HR 0.76; 95% CI 0.61-0.94 and 0.67; 95% CI 0.53-0.83 for biennial and annual screening, respectively).

Intakes of grains, meats, proteins, coffee, alcohol, aspirin, fiber, fruits and vegetables were not found to be associated with colorectal cancer mortality, the researchers reported.

“Our study confirms the relationship between BMI and long-term colorectal cancer mortality,” the study authors concluded. “Modulation of BMI may reduce risk of CRC mortality.”


1Shaukat A, Dostal A, Menk J, Church TR. BMI Is a Risk Factor for Colorectal Cancer Mortality. Dig Dis Sci. 2017 Sep;62(9):2511-2517. doi: 10.1007/s10620-017-4682-z. Epub 2017 Jul 21. PubMed PMID: 28733869.

Comments are closed here.


Related Articles

Effective Metrics Help VA Exceed National Goal for Colorectal Cancer Screening

More Than 80% of Patients Meet Recommendations LOS ANGELES—More than four out of five veterans eligible for colorectal cancer screening have been screened, putting the largest healthcare system in the United States among the top... View Article

More Options, Better Survival for Veterans With Metastatic Pancreatic Cancer

ALBANY, NY—Pancreatic cancer remains one of the deadliest malignancies in the United States, but new therapies can extend life and improve quality of life for many patients. That is especially the case at the VA,... View Article


U.S. Medicine Recommends


More From oncology

Oncology

Effective Metrics Help VA Exceed National Goal for Colorectal Cancer Screening

More Than 80% of Patients Meet Recommendations LOS ANGELES—More than four out of five veterans eligible for colorectal cancer screening have been screened, putting the largest healthcare system in the United States among the top... View Article

Oncology

More Options, Better Survival for Veterans With Metastatic Pancreatic Cancer

ALBANY, NY—Pancreatic cancer remains one of the deadliest malignancies in the United States, but new therapies can extend life and improve quality of life for many patients. That is especially the case at the VA,... View Article

Oncology

Military Risks for Ocular Surface Squamous Neoplasia

MIAMI—While a variety of risk factors have been evaluated in ocular surface squamous neoplasia, few studies have assessed risk factors specific to the armed forces veteran population. A report in the journal Eye and Vision... View Article

Oncology

Antibiotics Appear to Inhibit Tumor Activity in CTCL

AARHUS, DENMARK—Do CD4 T cell responses to  Staphylococcus aureus inadvertently enhance neoplastic progression in models of skin cancer and cutaneous T cell lymphoma? A prospective study in the journal Blood examined that question, exploring the... View Article

Oncology

Lower Dose Cisplatin Preferable in Squamous Cell Carcinoma

PHILADELPHIA—Chemoradiotherapy is commonly used for nonoperative treatment of locally advanced head and neck squamous cell carcinoma. The issue, according to a recent study, is that the standard dose of 100 mg/m2 cisplatin every three weeks is... View Article

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up